Jeffrey Cretel suffered from a complex neurological disorder with development delay, particularly in terms of understanding and producing speech. He experienced multiple Type I seizures that interfered with his development and made him unable to walk or function during the day. Several specialists from The
CHOC Neuroscience Institute were involved with the diagnosis and treatment plan, which included anti-seizure medications, special vitamins to control his metabolic disorder, and the insertion of the Vagal Nerve Stimulator, a new device that helps reduce seizure frequency and severity. With this combined treatment approach, Jeffrey's speech has improved and he is seizure free. Nearly all of the 40 patients who have received the Stimulator through the Institute have shown improvement in seizure control.